Cataract Clinical Trial
Official title:
Retrospective, Observational, Monocenter And Single-Arm Trial Following Subjects Bilaterally Implanted With Mini Well Ready For 2 Years After The Second Eye Implant
Verified date | March 2021 |
Source | SIFI SpA |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The study objective is to evaluate the visual performance of MINI WELL Ready at 24 months following the second eye implant. The objectives of safety are to evaluate the rate of Secondary Surgical Interventions related to the optical properties of the IOL for first and second operative eye separately at 24 months and the rate of visual disturbances and distortions as reported by the subjects as detected by using the Halo & Glare Simulator.
Status | Completed |
Enrollment | 23 |
Est. completion date | November 19, 2020 |
Est. primary completion date | November 19, 2020 |
Accepts healthy volunteers | |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: • Previous enrolment in the PSM8 study in the period from March, 1st 2014 to March, 31st 2016 with the following: - Any gender and age above 18 years. - Cataract or Refractive Lens Exchange (RLE) surgery; will be included patients submitted to conventional phacoemulsification as to femtolaser procedure; no specification regarding corneal incision size and position. - Symmetrical preoperative keratometric astigmatism < 1.00 D. - Healthy corneas, not surgically treated Exclusion Criteria: - Previous corneal surgery (i.e. pterygium, refractive surgery). - Eye diseases with visual acuity < 20/32. - Pseudoexfoliation. - Abnormal pupil size and position. - Use of contact lens 30 days before the preoperative visit. - Corneal warpage. |
Country | Name | City | State |
---|---|---|---|
Italy | U.O. Oftalmologia I Dipartimento di Scienze Mediche di Base, Neuroscienze e Organi di Senso Università degli Studi di Bari "Aldo Moro" | Bari |
Lead Sponsor | Collaborator |
---|---|
SIFI SpA | Opera CRO, a TIGERMED Group Company |
Italy,
Becker KA, Martin M, Rabsilber TM, Entz BB, Reuland AJ, Auffarth GU. Prospective, non-randomised, long term clinical evaluation of a foldable hydrophilic single piece intraocular lens: results of the Centerflex FDA study. Br J Ophthalmol. 2006 Aug;90(8):9 — View Citation
Blaylock JF, Si Z, Vickers C. Visual and refractive status at different focal distances after implantation of the ReSTOR multifocal intraocular lens. J Cataract Refract Surg. 2006 Sep;32(9):1464-73. — View Citation
Jiang T, Jiang J, Zhou Y, Zhao GQ, Li H, Zhao SY. Cataract surgery in aged patients: phacoemulsification or small-incision extracapsular cataract surgery. Int J Ophthalmol. 2011;4(5):513-8. doi: 10.3980/j.issn.2222-3959.2011.05.11. Epub 2011 Oct 18. — View Citation
Kohnen T, Klaproth OK, Bühren J. Effect of intraocular lens asphericity on quality of vision after cataract removal: an intraindividual comparison. Ophthalmology. 2009 Sep;116(9):1697-706. doi: 10.1016/j.ophtha.2009.03.052. Epub 2009 Jul 29. — View Citation
Lehmann R, Waycaster C, Hileman K. A comparison of patient-reported outcomes from an apodized diffractive intraocular lens and a conventional monofocal intraocular lens. Curr Med Res Opin. 2006 Dec;22(12):2591-602. — View Citation
Leyland M, Zinicola E. Multifocal versus monofocal intraocular lenses in cataract surgery: a systematic review. Ophthalmology. 2003 Sep;110(9):1789-98. Review. — View Citation
Packer M, Fine IH, Hoffman RS. Aspheric intraocular lens selection: the evolution of refractive cataract surgery. Curr Opin Ophthalmol. 2008 Jan;19(1):1-4. — View Citation
Steinert RF. Visual outcomes with multifocal intraocular lenses. Curr Opin Ophthalmol. 2000 Feb;11(1):12-21. Review. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Subjective Refraction | 26 months | ||
Primary | Binocular Defocus Curve | Binocular Defocus Curve (+2.0 D to -4.0 D in 0.5 D increments) | 26 months | |
Primary | UDVA | Monocular and Binocular Uncorrected Distance Visual Acuity (UDVA) at 4m | 26 months | |
Primary | CDVA | Monocular and Binocular Corrected Distance Visual Acuity (CDVA) at 4m | 26 months | |
Primary | UIVA at 100 cm | Monocular and Binocular Uncorrected Intermediate Visual Acuity at 100 cm (100% and 10% contrast) | 26 months | |
Primary | DCIVA at 100 cm | Monocular and Binocular Distance Corrected Intermediate Visual at 100 cm (100% and 10% contrast) | 26 months | |
Primary | UIVA at 60 cm | Monocular and Binocular Uncorrected Intermediate Visual Acuity at 60 cm (100% and 10% contrast) | 26 months | |
Primary | DCIVA at 60 cm | Monocular and Binocular Distance Corrected Intermediate Visual Acuity at 60 cm (100% and 10% contrast) | 26 months | |
Primary | UNVA | Monocular and Binocular Uncorrected Near Visual Acuity at 40cm (100% contrast) | 26 months | |
Primary | DCNVA | Monocular and Binocular Distance Corrected Near Visual Acuity at 40cm (100% contrast) | 26 months | |
Primary | Contrast Sensitivity | Binocular Contrast Sensitivity with correction for distance | 26 months | |
Primary | Reading Performance | Binocular Reading Performance with and without correction for distance | 26 months | |
Primary | VR-11R | Visual Function -11R Questionnaire from 4 (without difficulties) to 0 (performance impossible due to difficulties) | 26 months | |
Secondary | Postoperative Complications Rate of postoperative complication | 26 months | ||
Secondary | Subjective Posterior Capsule Opacification | Subjective assessment through slit lamp | 20-26 months | |
Secondary | Posterior Capsulotomy | 26 months | ||
Secondary | Adverse Events including SSIs | 26 months | ||
Secondary | Device Deficiencies | Descriptive assessment | 26 months | |
Secondary | Photic Phenomena Assessment | Using the Halo and Glare Simulator software | 26 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04685538 -
Chloroprocaine 3% Gel Eye Drop as Topical Anestheticsin Phacoemulsification.
|
Phase 3 | |
Recruiting |
NCT06060041 -
IC-8 Apthera IOL New Enrollment Post Approval Study
|
||
Recruiting |
NCT05518539 -
Evaluation of Quality of Vision and Visual Outcomes With Bilateral Implantation of the Clareon PanOptix Intraocular Lens
|
||
Recruiting |
NCT05271942 -
Tilt and Tumble vs Divide and Conquer - a Unique Comparison of the Two Cataract Surgery Methods
|
N/A | |
Active, not recruiting |
NCT04778501 -
PMCF Study on Monofocal Toric IOL (PODEYE TORIC) in Asia
|
N/A | |
Completed |
NCT05062564 -
Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye
|
N/A | |
Completed |
NCT03751033 -
Influence of DisCoVisc Ophthalmic Viscosurgical Device (OVD) on Intraoperative Aberrometry Readings
|
N/A | |
Completed |
NCT02529488 -
Investigation of AcrySof® IQ PanOptix™ Presbyopia-Correcting Intraocular Lens (IOL) Model TFNT00
|
N/A | |
Completed |
NCT04539548 -
A Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract
|
Phase 3 | |
Completed |
NCT03740659 -
Evaluation Of Aqueous Humor Of Levofloxacin-Dexamethasone Eye Drops And Of Its Components In Patients Undergoing Cataract Surgery
|
Phase 2 | |
Completed |
NCT03494257 -
Effect of Fixed Brinzolamide-brimonidine Combination on Intraocular Pressure After Phacoemulsification
|
N/A | |
Completed |
NCT05119127 -
Rotational Stability of Acrysof IQ Vivity Extended Vision Toric IOL and Refractive Visual Outcome.
|
N/A | |
Active, not recruiting |
NCT04271709 -
Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)
|
N/A | |
Recruiting |
NCT03713268 -
Intraoperative OCT Guidance of Intraocular Surgery II
|
||
Completed |
NCT03739528 -
Levo-Dexa vs. Tobra+Dexa for Prevention and Treatment of Inflammation and Prevention of Infection in Cataract Surgery
|
Phase 3 | |
Completed |
NCT02888210 -
A Study Assessing Safety and Efficacy of MD-15 Intraocular Lens in Patients With Aphakic Eye After Cataract Surgery
|
Phase 3 | |
Completed |
NCT03356847 -
Evaluation of the Rotational Stability of the Monofocal SISA Implant Following Cataract Surgery
|
N/A | |
Completed |
NCT04332640 -
Clinical Evaluation of the Next Generation Phaco System
|
N/A | |
Recruiting |
NCT03638726 -
Subconjunctival Atropine and Intracameral Epinephrine for Pupil Dilation in Phacoemulsification
|
Phase 4 | |
Completed |
NCT03050697 -
Evaluation of the Safety and Performance of the HARMONI® Toric Lens
|
N/A |